论文部分内容阅读
目的:探讨一种新型宫颈癌筛查方法——TruScreen在宫颈癌及癌前病变筛查中的应用价值。方法:103名妇女同时接受宫颈刮片和TruScreen宫颈癌筛查,宫颈刮片异常或TruScreen宫颈癌筛查异常者在阴道镜下进行活检,行组织病理学检验。结果:TruScreen宫颈癌筛查32例异常者,6例经阴道镜检查诊断为宫颈上皮内瘤变(CIN),9例诊断为可疑CIN,而病理学检查确诊19例CIN。宫颈刮片异常者仅3例,其中2例经阴道镜活检确诊为CIN。结论:TruScreen宫颈癌筛查对宫颈癌前期病变有更高的检出率,检出病变准确度与宫颈刮片比较无差异。TruScreen可以起到早期诊断宫颈癌前期病变、预防宫颈癌发生的作用。
Objective: To explore a new screening method for cervical cancer - the value of TruScreen in screening cervical cancer and precancerous lesions. Methods: 103 women underwent cervical smear and TruScreen cervical cancer screening at the same time. Abnormal cervical smears or TruScreen cervical cancer screening were biopsied by colposcopy and histopathologically tested. RESULTS: Thirty-two cases of cervical cancer were screened by TruScreen cervical cancer. Six cases were diagnosed as cervical intraepithelial neoplasia by colposcopy. Nine cases were diagnosed as suspicious CIN, while 19 cases were diagnosed by pathology. Cervical smear abnormalities were only 3 cases, of which 2 cases were diagnosed by colposcopy biopsy CIN. Conclusion: TruScreen cervical cancer screening has a higher detection rate of cervical precancerous lesions, detection of lesions with no difference in cervical smear. TruScreen can play an early diagnosis of cervical precancerous lesions, the role of prevention of cervical cancer.